DK0850298T3 - Nervetransplantation under anvendelse af pluripotente neuroepitelceller - Google Patents

Nervetransplantation under anvendelse af pluripotente neuroepitelceller

Info

Publication number
DK0850298T3
DK0850298T3 DK96930260T DK96930260T DK0850298T3 DK 0850298 T3 DK0850298 T3 DK 0850298T3 DK 96930260 T DK96930260 T DK 96930260T DK 96930260 T DK96930260 T DK 96930260T DK 0850298 T3 DK0850298 T3 DK 0850298T3
Authority
DK
Denmark
Prior art keywords
neuroepithelial cells
pluripotent neuroepithelial
nerve transplantation
cells
pluripotent
Prior art date
Application number
DK96930260T
Other languages
Danish (da)
English (en)
Inventor
John Institute Of Psych Sinden
Alan Institute Of Psyc Jeffrey
Helen Institute Of Psyc Hodges
Timothy C O Inst Of Ps Kershaw
Fiza University Rashid-Doubell
Original Assignee
Reneuron Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reneuron Ltd filed Critical Reneuron Ltd
Application granted granted Critical
Publication of DK0850298T3 publication Critical patent/DK0850298T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/24—Interferons [IFN]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/395—Thyroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/90—Polysaccharides
    • C12N2501/91—Heparin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
DK96930260T 1995-09-12 1996-09-12 Nervetransplantation under anvendelse af pluripotente neuroepitelceller DK0850298T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9518606.0A GB9518606D0 (en) 1995-09-12 1995-09-12 Neural transplantation
PCT/GB1996/002251 WO1997010329A1 (en) 1995-09-12 1996-09-12 Neural transplantation using pluripotent neuroepithelial cells

Publications (1)

Publication Number Publication Date
DK0850298T3 true DK0850298T3 (da) 2003-09-15

Family

ID=10780583

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96930260T DK0850298T3 (da) 1995-09-12 1996-09-12 Nervetransplantation under anvendelse af pluripotente neuroepitelceller

Country Status (21)

Country Link
US (3) US7048921B2 (hu)
EP (1) EP0850298B1 (hu)
JP (1) JP4280872B2 (hu)
KR (1) KR19990044606A (hu)
CN (1) CN1193345A (hu)
AT (1) ATE242316T1 (hu)
AU (1) AU711563B2 (hu)
CA (1) CA2231436C (hu)
CZ (1) CZ296669B6 (hu)
DE (1) DE69628566T2 (hu)
DK (1) DK0850298T3 (hu)
ES (1) ES2196172T3 (hu)
GB (1) GB9518606D0 (hu)
HK (1) HK1009154A1 (hu)
HU (1) HUP9802091A3 (hu)
NO (1) NO981072L (hu)
PL (1) PL186777B1 (hu)
PT (1) PT850298E (hu)
RU (1) RU2185833C2 (hu)
SK (1) SK285816B6 (hu)
WO (1) WO1997010329A1 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996014400A1 (en) 1994-11-08 1996-05-17 Bradley Michael John Stringer Human cell-lines
GB9518606D0 (en) * 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
GB9904281D0 (en) * 1999-02-24 1999-04-21 Reneuron Ltd Transplantation
GB9907243D0 (en) * 1999-03-29 1999-05-26 Reneuron Ltd Therapy
US6399384B1 (en) * 1999-09-17 2002-06-04 Reneuron Limited Conditional immortalization of cells
KR100801764B1 (ko) * 1999-09-17 2008-02-05 레뉴런 리미티드 세포의 조건부 불멸화
US6465215B1 (en) 1999-12-14 2002-10-15 Reneuron Limited Identification of cells for transplantation
GB0005856D0 (en) * 2000-03-10 2000-05-03 Reneuron Ltd Genetic constructs
GB0125773D0 (en) * 2001-10-26 2001-12-19 Reneuron Ltd Constructs
DE602005002430T2 (de) 2004-09-30 2008-06-19 Reneuron Ltd., Guildford Zelllinie
CN101772580B (zh) * 2007-05-29 2015-11-25 克里斯多佛·B·里德 专能细胞群的生产和使用方法
GB0822246D0 (en) 2008-12-05 2009-01-14 Reneuron Ltd Composition
GB0902034D0 (en) 2009-02-06 2009-03-11 Reneuron Ltd Method
GB201011589D0 (en) * 2010-07-09 2010-08-25 Reneuron Ltd Therapeutic cells
US20150232662A1 (en) * 2014-02-20 2015-08-20 Sabic Innovative Plastics Ip B.V. Thermoplastic composition and article
US20170173114A1 (en) * 2014-05-07 2017-06-22 Joslin Diabetes Center, Inc. Methods and compositions for induction of ucp1 expression
CN116590345B (zh) * 2023-05-06 2024-01-30 北京中医药大学 永生化小鼠足细胞系及其制备方法、分化方法和应用

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US28510A (en) * 1860-05-29 John e
US203483A (en) * 1878-05-07 Improvement in honey-boxes
US146821A (en) * 1874-01-27 Improvement in nose-pieces of nail-plate feeders
US1662A (en) * 1840-06-27 ariel nobris
US147873A (en) * 1874-02-24 Improvement in nasal yokes for animals
US913443A (en) * 1908-08-13 1909-02-23 Webster Full Expansion Rotary Engine Company Rotary engine.
NZ226750A (en) * 1987-10-29 1990-09-26 Amrad Corp Ltd Immortalisation of neural precursor cells by introducing a retrovirus vector containing a myc-oncogene
US5270191A (en) 1988-04-12 1993-12-14 Massachusetts Institute Of Technology Method for manipulation of the cell types of eukaryotes
JPH03504799A (ja) 1988-04-12 1991-10-24 マサチューセッツ・インスティチュート・オブ・テクノロジー 真核細胞の細胞型を操作する方法
US5070191A (en) * 1989-04-27 1991-12-03 Ajinomoto Co., Inc. Demethylallosamidin and a process for production thereof
US5399493A (en) 1989-06-15 1995-03-21 The Regents Of The University Of Michigan Methods and compositions for the optimization of human hematopoietic progenitor cell cultures
WO1991009936A1 (en) * 1989-12-26 1991-07-11 Hana Biologics, Inc. Proliferated neuron progenitor cell product and process
US5612211A (en) 1990-06-08 1997-03-18 New York University Stimulation, production and culturing of hematopoietic progenitor cells by fibroblast growth factors
RU2028089C1 (ru) * 1990-10-16 1995-02-09 Украинский научно-исследовательский институт нейрохирургии Способ лечения апаллического синдрома
US5851832A (en) 1991-07-08 1998-12-22 Neurospheres, Ltd. In vitro growth and proliferation of multipotent neural stem cells and their progeny
CA2113118C (en) * 1991-07-08 2002-09-17 Samuel Weiss Novel growth factor-responsive progenitor cells which can be proliferated in vitro
KR950700403A (ko) 1992-03-04 1995-01-16 죤 제이. 쉬바르츠 조혈 간세포의 배양 및 그것의 유전공학(culturing of hematopoietic stem cells and their genetic engineering)
EP0696205B1 (en) 1993-04-13 2002-01-23 GOVERNMENT OF THE UNITED STATES OF AMERICA, as repr. by THE SECR. OF THE DEPT. OF HEALTH AND HUMAN SERVICES AND HIS SUCCESSORS Use of neuro-derived fetal cell lines for transplantation therapy
US5753491A (en) 1993-04-13 1998-05-19 Us Health Use of neuro-derived fetal cell lines for transplantation therapy
WO1996014400A1 (en) 1994-11-08 1996-05-17 Bradley Michael John Stringer Human cell-lines
JPH10509592A (ja) * 1994-11-14 1998-09-22 ニューロスフィアーズ ホウルディングス リミテッド 神経幹細胞増殖調節
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
GB9517263D0 (en) * 1995-08-23 1995-10-25 Cancer Res Campaign Tech Expression systems
GB9518606D0 (en) 1995-09-12 1995-11-15 Inst Of Psychiatry Neural transplantation
US5588692A (en) * 1995-10-11 1996-12-31 General Motors Corporation Push-out vehicle side door
WO1998007841A1 (en) 1996-08-19 1998-02-26 University Of Massachusetts Embryonic or stem-like cell lines produced by cross species nuclear transplantation
SE9604322D0 (sv) * 1996-11-25 1996-11-25 Astra Ab Bacterial antigens and vaccine compositions II
US20020123143A1 (en) 1997-08-22 2002-09-05 Jean Toma Multipotent stem cells from peripheral tissues and uses thereof
ES2246085T3 (es) * 1998-05-07 2006-02-01 University Of South Florida Celulas de medula osea como fuente de neuronas util para reparar la medula espinal y el cerebro.
US5958767A (en) 1998-08-14 1999-09-28 The Children's Medical Center Corp. Engraftable human neural stem cells
GB9904281D0 (en) 1999-02-24 1999-04-21 Reneuron Ltd Transplantation
GB9907243D0 (en) * 1999-03-29 1999-05-26 Reneuron Ltd Therapy
US6399384B1 (en) 1999-09-17 2002-06-04 Reneuron Limited Conditional immortalization of cells
US6465215B1 (en) * 1999-12-14 2002-10-15 Reneuron Limited Identification of cells for transplantation
WO2001066698A1 (en) 2000-03-09 2001-09-13 Cryo-Cell International, Inc. Human cord blood as a source of neural tissue for repair of the brain and spinal cord
US7250294B2 (en) 2000-05-17 2007-07-31 Geron Corporation Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
US7049072B2 (en) * 2000-06-05 2006-05-23 University Of South Florida Gene expression analysis of pluri-differentiated mesenchymal progenitor cells and methods for diagnosing a leukemic disease state
WO2001094541A2 (en) 2000-06-05 2001-12-13 University Of South Florida Human mesenchymal progenitor cell
WO2003029432A2 (en) 2001-10-03 2003-04-10 University Of South Florida Human mesenchymal progenitor cell
GB0125773D0 (en) * 2001-10-26 2001-12-19 Reneuron Ltd Constructs
DE602005002430T2 (de) * 2004-09-30 2008-06-19 Reneuron Ltd., Guildford Zelllinie

Also Published As

Publication number Publication date
AU6937596A (en) 1997-04-01
US20030147873A1 (en) 2003-08-07
CA2231436C (en) 2007-07-17
PL186777B1 (pl) 2004-02-27
US7048921B2 (en) 2006-05-23
HUP9802091A2 (hu) 1998-12-28
ATE242316T1 (de) 2003-06-15
US20060051326A1 (en) 2006-03-09
EP0850298B1 (en) 2003-06-04
US7371374B2 (en) 2008-05-13
NO981072D0 (no) 1998-03-11
DE69628566T2 (de) 2004-05-06
RU2185833C2 (ru) 2002-07-27
GB9518606D0 (en) 1995-11-15
CN1193345A (zh) 1998-09-16
ES2196172T3 (es) 2003-12-16
DE69628566D1 (de) 2003-07-10
HUP9802091A3 (en) 2001-01-29
HK1009154A1 (en) 1999-05-28
JP4280872B2 (ja) 2009-06-17
PT850298E (pt) 2003-09-30
CZ55898A3 (cs) 1998-06-17
CZ296669B6 (cs) 2006-05-17
JPH11513242A (ja) 1999-11-16
NO981072L (no) 1998-05-12
US20010001662A1 (en) 2001-05-24
SK30698A3 (en) 1999-01-11
CA2231436A1 (en) 1997-03-20
EP0850298A1 (en) 1998-07-01
SK285816B6 (sk) 2007-09-06
PL325646A1 (en) 1998-08-03
KR19990044606A (ko) 1999-06-25
AU711563B2 (en) 1999-10-14
WO1997010329A1 (en) 1997-03-20

Similar Documents

Publication Publication Date Title
DK0850298T3 (da) Nervetransplantation under anvendelse af pluripotente neuroepitelceller
WO2001036589A3 (en) Human ex vivo immune system
WO1997012960A3 (en) Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in a bio-artificial liver system
DE69609222D1 (de) Partikel auf Polyaminosäure(n)basis zur Verwendung als Wirkstoffträger sowie deren Herstellungsverfahren
SE0000305L (sv) Förfarande och anordning vid superstruktur till implantat
GB9308271D0 (en) Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
ES2196082T3 (es) Analagos del factor de crecimiento de queratinocitos.
DE69635924D1 (de) Isolierung und züchtung von schwannzellen
ATE464910T1 (de) Humane cd80-mutante und zusammensetzungen und methoden zu deren herstellung und verwendung
DE69637709D1 (de) Durch elektroporation vermittelter molekulartransfer in intakten pflanzen
DK0952772T3 (da) Fremgangsmåder til anvendelse af mononukleare phagocytter til at fremme axonal regeneration
DE58906338D1 (de) Kombination von Angiotensin-Converting-Enzyme-Hemmern mit Kaliumkanal-Modulatoren sowie deren Verwendung in Arzneimitteln.
HUP9802531A2 (hu) Eljárás haematopoeticus stem sejtek mobilizálására
AU5391886A (en) Method and device for the in vitro culture of plant cells and organs, as well as for the micropropagation and regeneration of complete plants
CA2380943A1 (en) Mechanically elongated neuronal cells and methods for producing and using these cells
DE69725100D1 (de) Verfahren und Satz zur Prüfung der Drogenempfindlichkeit von Mikroben, sowie Verfahren und Satz zur Missung der minimumhemmenden Konzentration von Mikroorganismen
DK0883406T3 (da) Anvendelse af IL-7 til behandling af autoimmune sygdomme og især insulinafhængig diabe-tesmellitus i særdeleshed
ES2132027A1 (es) Desarrollo de una piel artificial mediante cultivo de queratinocitos sobre una base de fibrina y fibroblastos humanos y metodo de preparacion de esta piel para trasplante.
FI960839A (fi) Uusia tripeptidejä, jotka ovat käyttökelpoisia immuuni- ja CNS-terapiassa
AU7577091A (en) Process for the artificial stimulation of cells and cyte culture device
ATE269090T1 (de) Tiermodell zum testen von arzneistoffen zur behandlung von leukämie oder hiv
EP0142109A3 (en) Macromolecules extracted from cultured mesenchymal cells for the treatment of degenerative diseases
ATE334672T1 (de) Ginkolide zur hemmung der membranexpression
ATE206619T1 (de) Komplex aus antigen und zellbestandteil, verfahren zur dessen herstellung und therapeutische verwendungen
DE69522706T2 (de) Heterocyclische verbindungen, deren herstellung und verwendung